ReviewFrontiers in pharmacology2020

Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies.

Jia Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.